Recombinant Human IFNA14 Protein，His

IFNA14, a member of the interferon-alpha (IFN-α) family, plays a crucial role in the immune response against viral infections. This protein, known for its antiviral, antiproliferative, and immunomodulatory functions, is expressed in response to viral stimuli and has been extensively studied for its therapeutic potential in treating viral diseases, certain cancers, and autoimmune disorders. The interest in IFNA14 is particularly significant due to its ability to induce the transcription of various genes involved in the antiviral response, enhance natural killer cell activity, and modulate adaptive immune responses. Recent advancements in recombinant DNA technology have enabled the production of IFNA14 as a recombinant protein, facilitating detailed functional studies and the exploration of its therapeutic applications. Researchers have been investigating various aspects of IFNA14, including its structure, signaling pathways, and interaction with receptors to better understand its role in the immune system. Moreover, the comparison of IFNA14’s efficacy and mechanisms with other interferons may yield valuable insights into optimizing its use in clinical settings. Given the rising incidence of viral infections and the need for effective therapies, the ongoing research on IFNA14 provides a promising avenue for the development of novel antiviral treatments and immunotherapeutic strategies.